U.S. Communications Stock News

If you have been eyeing Regal Rexnord and wondering, “What should I do next?” you are not alone. Investors are trying to navigate the waters after seeing the stock trade at $145.04 most recently, with a modest 1.3% gain over the past week and a 1.1% uptick for the past month. Still, Regal Rexnord’s longer-term chart tells a more mixed story: shares are down 5.4% year-to-date and off 13.7% from where they stood a year ago. Those who have held on for five years are sitting on a 69.1%...

We can readily understand why investors are attracted to unprofitable companies. For example, Palladyne AI...

With a price-to-earnings (or "P/E") ratio of 4.2x MV Oil Trust ( NYSE:MVO ) may be sending very bullish signals at the...

Key Insights Institutions' substantial holdings in Axogen implies that they have significant influence over the...

Dorman Products, Inc. ( NASDAQ:DORM ), is not the largest company out there, but it led the NASDAQGS gainers with a...

Key Insights Insiders appear to have a vested interest in Waton Financial's growth, as seen by their sizeable ownership...

Key Insights Tecnoglass' estimated fair value is US$47.53 based on 2 Stage Free Cash Flow to Equity Tecnoglass is...

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

There wouldn't be many who think BARK, Inc.'s ( NYSE:BARK ) price-to-sales (or "P/S") ratio of 0.3x is worth a mention...

The FDA’s acceptance of Replimune Group’s resubmitted Biologics License Application for RP1, combined with nivolumab, has sparked renewed optimism among investors. This regulatory milestone follows months of addressing agency feedback and signals real progress for the company’s advanced melanoma program. See our latest analysis for Replimune Group. The FDA's green light for Replimune's RP1 application sent the share price soaring nearly 99% in a single day, erasing months of slow declines and...

As the U.S. stock market begins the week on a high note, buoyed by gains across major indices and ongoing developments in trade and inflation data, investors are keenly observing opportunities amid economic uncertainties like the prolonged government shutdown. In this environment, identifying stocks that may be trading below their intrinsic value can offer potential for growth, making it crucial to consider factors such as financial health and market position when evaluating investment...

As of October 2025, the U.S. stock market has shown robust gains, with major indices such as the Nasdaq and S&P 500 closing higher amid a backdrop of ongoing government shutdowns and fluctuating commodity prices. In this environment, growth companies with substantial insider ownership can be particularly appealing to investors, as they often indicate strong management confidence and alignment with shareholder interests.

As the U.S. markets experience a strong start to the week, with major indices climbing over 1%, investors are keenly watching for corporate earnings and economic data that could influence Federal Reserve decisions on interest rates. In this environment of heightened market activity, dividend stocks remain an attractive option for those seeking steady income and potential growth, as they can offer stability amid broader market fluctuations.

On October 20, 2025, Safe Pro Group Inc. announced a private placement of 2,000,000 common shares at US$7 per share for gross proceeds of US$14,000,000, with Ondas Holdings Inc. as the lead new investor and expected closing on October 22, 2025, subject to standard conditions. In addition, Safe Pro Group recently filed a US$100 million shelf registration, opening the door to a broad range of potential future securities offerings that could support the company's funding needs. We'll explore...

At its 16th annual Jamf Nation User Conference in Denver earlier this month, Jamf announced the beta release of AI Analysis for Executive Threat Protection, an artificial intelligence-powered tool that accelerates and simplifies mobile forensic analysis for device security teams. This upgrade enables rapid incident response and translates complex forensic data into actionable steps, equipping organizations with more efficient tools to protect high-risk users without requiring specialized...

Artiva Biotherapeutics (ARTV) recently secured Fast Track Designation from the U.S. FDA for its AlloNK therapy in combination with rituximab, a treatment aimed at refractory rheumatoid arthritis. This recognition has captured significant market attention. See our latest analysis for Artiva Biotherapeutics. Artiva Biotherapeutics shares rocketed after news of the FDA Fast Track Designation, notching a remarkable 108.7% 1-month share price return and delivering 132.9% over the past 90 days...

Kadant Inc. ( NYSE:KAI ), is not the largest company out there, but it saw a decent share price growth of 11% on the...

As the U.S. stock market experiences gains across major indices, with the Dow Jones, S&P 500, and Nasdaq all showing positive momentum, investors are keenly observing corporate earnings reports and inflation data that could influence future interest rate decisions. In this environment of cautious optimism and strategic positioning, identifying undervalued stocks like Extreme Networks can offer potential opportunities for those looking to invest in equities estimated below their fair value.

As the U.S. stock market begins the week with gains across major indices, investors are closely watching corporate earnings and economic indicators that may influence Federal Reserve decisions on interest rates. In this environment, companies with strong growth potential and significant insider ownership can offer unique insights into confidence levels from those most familiar with their operations.

As the U.S. stock market begins the week on a positive note, with major indices like the Nasdaq, S&P 500, and Dow Jones Industrial Average showing gains, investors are keenly observing movements amid ongoing corporate earnings reports and economic data releases. While penny stocks may seem like a throwback to earlier trading days, they remain an intriguing area for investment due to their potential for significant returns when backed by strong financials. These smaller or newer companies can...

The United States market has seen a positive start to the week, with major indices such as the Nasdaq, S&P 500, and Dow Jones Industrial Average all experiencing gains amid a backdrop of ongoing corporate earnings reports and economic indicators like inflation data influencing investor sentiment. In this environment, small-cap stocks, often overlooked, can present unique opportunities for investors seeking growth potential, especially as the market navigates through economic shifts and...

As the U.S. stock market experiences gains across major indices, with the tech-heavy Nasdaq and blue-chip Dow Jones Industrial Average showing positive momentum, investors are keeping a close eye on corporate earnings and inflation data that could influence Federal Reserve decisions. In this climate of cautious optimism, dividend stocks like First Merchants offer potential stability and income, making them an attractive consideration for those navigating today's unpredictable economic landscape.

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

New Horizon Aircraft (NasdaqCM:HOVR) is making headlines after announcing a partnership and purchase agreement with Pratt & Whitney Canada for the PT6A engine, which is set to power its Cavorite X7 hybrid eVTOL aircraft. The deal marks meaningful progress on prototype development and signals the company’s commitment to delivering practical innovation in advanced air mobility. See our latest analysis for New Horizon Aircraft. Shares of New Horizon Aircraft have soared in 2025, supercharged by...